NFKB1 common variants and PPP1R13L and CD3EAP in relation to lung cancer risk in a Chinese population

Gene

Volumn 567, Issue 1, 2015, Pages 31-35

  Yin, Jiaoyang ^a   Yin, Mengfan ^b   Vogel, Ulla ^c   Wu, Yuhong ^a   Yao, Tao ^d   Cheng, Yanhua ^e   Sun, Zhenxiang ^a   Hou, Wei ^f   Wang, Chunhong ^a  

^a SHENYANG MEDICAL COLLEGE   (China)

^b TIANJIN FIFTH CENTRAL HOSPITAL   (China)

^c NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^d Shenyang He Eye Hospital   (China)

^e Department of Morphology Liaoning He Medical College   (China)

^f PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Chinese; Common variants; Interaction; Lung cancer; NFKB1 and PPP1R13L and CD3EAP

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CD3E MOLECULE EPSILON ASSOCIATED PROTEIN ANTISENSE TO ERCC1 GENE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAN CHINESE; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NF KAPPA B INTERACTING PROTEIN 1 GENE; NUCLEAR FACTOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS 1 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TUMOR GENE; WILD TYPE; AGED; CHINA; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; RISK FACTOR;

CD3EAP PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB1 PROTEIN, HUMAN; PPP1R13L PROTEIN, HUMAN; REPRESSOR PROTEIN; SIGNAL PEPTIDE;

AGED; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; REPRESSOR PROTEINS; RISK FACTORS;

EID: 84930482412     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.04.059     Document Type: Article

References (18)

1. Arisawa T., Tahara T., Shiroeda H., Yamada K., Nomura T., Yamada H., Hayashi R., Matsunaga K., Otsuka T., Nakamura M., Shimasaki T., Toshikuni N., Kawada N., Shibata T. Functional promoter polymorphisms of NFKB1 influence susceptibility to the diffuse type of gastric cancer. Oncol. Rep. 2013, 30:3013-3019.
2. Chang E.T., Birmann B.M., Kasperzyk J.L., Conti D.V., Kraft P., Ambinder R.F., Zheng T., Mueller N.E. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 2009, 18:976-986.
3. Chen Z. Medical Genetics 2001, 262-263. People Hygienic Press, Beijing, China. 1st ed.
4. Dzhugashvili M., Luengo-Gil G., García T., González-Conejero R., Conesa-Zamora P., Escolar P.P., Calvo F., Vicente V., Ayala de la Peña F. Role of genetic polymorphisms in NFKB-mediated inflammatory pathways in response to primary chemoradiation therapy for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2014, 90:595-602.
5. Gao J., Xu H.L., Gao S., Zhang W., Tan Y.T., Rothman N., Purdue M., Gao Y.T., Zheng W., Shu X.O., Xiang Y.B. Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China. BMJ Open 2014, 4:e004427.
6. Huang D., Yang L., Liu Y., Zhou Y., Guo Y., Pan M., Wang Y., Tan Y., Zhong H., Hu M., Lu W., Ji W., Wang J., Ran P., Zhong N., Zhou Y., Lu J. Functional polymorphisms in NFκB1/IκBα predict risks of chronic obstructive pulmonary disease and lung cancer in Chinese. Hum. Genet. 2013, 132:451-460.
7. Lu R., Gao X., Chen Y., Ni J., Yu Y., Li S., Guo L. Association of an NFKB1 intron SNP (rs4648068) with gastric cancer patients in the Han Chinese population. BMC Gastroenterol. 2012, 12:87.
8. Mohd Suzairi M.S., Tan S.C., Ahmad Aizat A.A., Mohd Aminudin M., Siti Nurfatimah M.S., Andee Z.D., Ankathil R. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol. 2013, 37:634-638.
9. Ritchie M.D., Hahn L.W., Roodi N., Bailey L.R., Dupont W.D., Parl F.F., Moore J.H. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 2001, 69:138-147.
10. Shiels M.S., Engels E.A., Shi J., Landi M.T., Albanes D., Chatterjee N., Chanock S.J., Caporaso N.E., Chaturvedi A.K. Genetic variation in innate immunity and inflammation pathways associated with lung cancer risk. Cancer 2012, 118:5630-5636.
11. Simpson M.A., Cook R.W., Solanki P., Patton M.A., Dennis J.A., Crosby A.H. A mutation in NFkappaB interacting protein 1 causes cardiomyopathy and woolly haircoat syndrome of Poll Hereford cattle. Anim. Genet. 2008, 40:42-46.
12. Solé X., Guinó E., Valls J., Iniesta R., Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 2006, 22:1928-1929.
13. Sun X.F., Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol. Histopathol. 2007, 22:1387-1398.
14. Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015, (Feb 4, Epub ahead of print). 10.3322/caac.21262.
15. Vangsted A.J., Klausen T.W., Gimsing P., Abildgaard N., Andersen N.F., Gregersen H., Nexø B.A., Vogel U.B. The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP. Ann. Hematol. 2011, 90:675-684.
16. Vogel U., Laros I., Jacobsen N.R., Thomsen B.L., Bak H., Olsen A., Bukowy Z., Wallin H., Overvad K., Tjønneland A., Nexø B.A., Raaschou-Nielsen O. Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat. Res. 2004, 546:65-74.
17. Xu Z., Taylor J.A. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009, 37:W600-5. (Web Server issue).
18. Yin J., Vogel U., Ma Y., Wang H., Wang C., Liang D., Yue L., Ma J., Li X. A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population. Lung Cancer 2012, 76:286-291.